Implications of MicroRNAs in the Treatment of Gefitinib-Resistant Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) represents about 85% of the reported cases of lung cancer. Acquired resistance to targeted therapy with epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs), such as gefitinib, is not uncommon. It is thus vital to explore novel strategies to rest...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Int J Mol Sci
मुख्य लेखकों: Sin, Thomas K., Wang, Fengfeng, Meng, Fei, Wong, S. C. Cesar, Cho, William C. S., Siu, Parco M., Chan, Lawrence W. C., Yung, Benjamin Y. M.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: MDPI 2016
विषय:
Review
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4783968/
https://ncbi.nlm.nih.gov/pubmed/26891293
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms17020237
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन